Accuray Incorporated (LON: 0H8I)
London flag London · Delayed Price · Currency is GBP · Price in USD
2.278
-0.011 (-0.49%)
Jan 23, 2025, 2:38 PM BST

Accuray Company Description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

In addition, it offers post-contract customer support, installation, training, and other professional services.

The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.

Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Accuray Incorporated
Country United States
Founded 1990
Industry Medical - Equipment & Services
Sector Healthcare
Employees 987
CEO Suzanne Winter

Contact Details

Address:
1240 Deming Way
Madison, Delaware 53717-1954
United States
Phone 608 824 2800
Website accuray.com

Stock Details

Ticker Symbol 0H8I
Exchange London Stock Exchange
Stock Type Common Stock
Fiscal Year July - June
Reporting Currency USD
ISIN Number US0043971052
SIC Code 3845

Key Executives

Name Position
Suzanne Winter Chief Executive Officer
Ali Pervaiz Chief Financial Officer